In Short term fluid replacement after trauma Sodium Chloride Infusion protects the patient from dehydration and electrolyte imbalance after any trauma or injury. Appropriate fluid replacement is very essential to restore normal brain activity and other vital functions of the body to promote healing as well as speedy recovery.
It is not known whether it is safe to consume alcohol with Sodium Chloride Infusion. Please consult your doctor.
Sodium Chloride Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Sodium Chloride Infusion during breastfeeding is not available. Please consult your doctor.
It is not known whether Sodium Chloride Infusion alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Sodium Chloride Infusion is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Caution should be advised in patients with renal impairment.
Sodium Chloride Infusion is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Sodium Chloride Infusion may not be needed in these patients. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Shreya Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: AXA Parenterals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Nirlife Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Claris Lifesciences Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Infutec Healthcare Limited || ₹14.5/tablet (25% cheaper)